Stratos Wealth Advisors LLC Cuts Position in The Clorox Company (NYSE:CLX)

Stratos Wealth Advisors LLC reduced its stake in shares of The Clorox Company (NYSE:CLX) by 8.6% in the third quarter, HoldingsChannel reports. The firm owned 1,735 shares of the company’s stock after selling 163 shares during the period. Stratos Wealth Advisors LLC’s holdings in Clorox were worth $283,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. OmniStar Financial Group Inc. purchased a new stake in shares of Clorox during the third quarter valued at about $824,000. Aspiriant LLC purchased a new stake in Clorox during the third quarter valued at approximately $202,000. Stonegate Investment Group LLC purchased a new stake in Clorox during the third quarter valued at approximately $219,000. Claro Advisors LLC boosted its stake in Clorox by 469.3% in the third quarter. Claro Advisors LLC now owns 36,644 shares of the company’s stock valued at $5,970,000 after acquiring an additional 30,207 shares in the last quarter. Finally, Sumitomo Mitsui DS Asset Management Company Ltd grew its holdings in Clorox by 12.5% in the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 12,857 shares of the company’s stock worth $2,095,000 after purchasing an additional 1,427 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Insider Buying and Selling

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the transaction, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 0.51% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of analysts have recently weighed in on the company. JPMorgan Chase & Co. raised their price objective on Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research report on Friday, October 11th. Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and boosted their price target for the stock from $174.00 to $187.00 in a research note on Tuesday, October 1st. Wells Fargo & Company decreased their price objective on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a research report on Wednesday, July 10th. Evercore ISI dropped their target price on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research report on Monday, October 14th. Finally, Barclays raised their price target on shares of Clorox from $130.00 to $137.00 and gave the stock an “underweight” rating in a report on Friday, October 11th. Six analysts have rated the stock with a sell rating, nine have given a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $150.14.

Clorox Price Performance

Shares of CLX opened at $159.23 on Wednesday. The business’s 50-day moving average is $159.96 and its two-hundred day moving average is $145.33. The company has a market capitalization of $19.77 billion, a P/E ratio of 82.50, a P/E/G ratio of 3.19 and a beta of 0.41. The Clorox Company has a fifty-two week low of $114.68 and a fifty-two week high of $169.09. The company has a debt-to-equity ratio of 5.04, a quick ratio of 0.63 and a current ratio of 1.03.

Clorox (NYSE:CLX) last posted its earnings results on Thursday, August 1st. The company reported $1.82 EPS for the quarter, topping the consensus estimate of $1.54 by $0.28. Clorox had a return on equity of 281.12% and a net margin of 3.95%. The firm had revenue of $1.90 billion for the quarter, compared to analyst estimates of $1.97 billion. Research analysts predict that The Clorox Company will post 6.64 earnings per share for the current year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be paid a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.06%. The ex-dividend date is Wednesday, October 23rd. Clorox’s dividend payout ratio is currently 252.85%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.